IgA nephropathy (IgA glomerulonephritis)

N14_IGA_NEPHROPATHY

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N08.2D89.80 Cause of death:* ICD-10 — N08.2*D89.80 2 out of 7 registries used, show all original rules.	863
4. Check minimum number of events None	863
5. Include endpoints None	863
6. Filter based on genotype QC (FinnGen only)	863

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF7

NAME	N14_IGA_NEPHROPATHY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N082&D8980
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N082&D8980
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to IgA nephropathy (IgA glomerulonephritis) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4061	1386	2634
Only index persons	3760	1331	2429
Unadjusted period prevalence (%)
Whole population	0.06	0.04	0.07
Only index persons	0.08	0.05	0.09
Median age at first event (years)
Whole population	46.98	42.39	49.52
Only index persons	46.14	42.13	48.34

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	863	312	551
Unadjusted period prevalence (%)	0.19	0.11	0.24
Median age at first event (years)	47.97	41.71	51.51

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
763: Matched controls
7628

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

+∞

323.0

762

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

3465.2

279.9

253

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

3363.8

273.9

248

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

91.8

272.4

295

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

92.2

263.2

285

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

145.0

259.7

266

Z94.0

ICD-10 Finland

Kidney transplant status

134.3

225.7

234

A11CC03

ATC

alfacalcidol; systemic

69.8

221.5

251

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

114.8

214.9

227

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

31.3

206.8

283

141

L04AA06

ATC

mycophenolic acid; systemic

74.0

194.0

218

127

Kela drug reimbursment

Transplant complication

68.1

189.5

216

A12AA04

ATC

calcium carbonate; oral

91.7

186.3

203

TK800

NOMESCO Finland

Hemodialysis

53.3

181.2

216

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

128.2

176.5

185

Z49.1

ICD-10 Finland

Extracorporeal dialysis

95.5

163.0

177

C03CA01

ATC

furosemide; systemic

9.4

160.7

423

892

B03XA02

ATC

darbepoetin alfa; parenteral

70.6

154.3

175

205

Kela drug reimbursment

Chronic hypertension

8.4

151.9

444

1080

137

Kela drug reimbursment

Uraemia requiring dialysis

138.5

148.5

155

N18.8

ICD-10 Finland

Other chronic renal failure

37.1

146.4

189

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

136.3

146.3

153

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

74.0

141.1

159

KA1AE

NOMESCO Finland

Kidney ultrasound examination

43.2

138.2

172

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

170.9

136.4

140

N18.0

ICD-10 Finland

End-stage renal disease

84.9

131.2

145

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

127.0

128.9

136

B05DA

ATC

Isotonic solutions

153.4

123.4

128

Z49.0

ICD-10 Finland

Preparatory care for dialysis

85.2

121.2

134

R80

ICD-10 Finland

Isolated proteinuria

97.8

119.6

130

Z49.2

ICD-10 Finland

Other dialysis

179.3

118.1

121

C08CA01

ATC

amlodipine; oral

6.0

114.0

453

1485

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

8.7

113.8

283

486

M04AA01

ATC

allopurinol; systemic

9.1

113.3

270

432

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

62.4

112.2

130

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

256.4

109.8

110

C09AA02

ATC

enalapril; systemic

7.0

109.7

330

746

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

13.3

109.2

204

H02AB04

ATC

methylprednisolone; systemic

7.6

105.6

291

575

B05DB

ATC

Hypertonic solutions

177.3

104.1

107

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

16.8

102.2

170

128

V03AE01

ATC

polystyrene sulfonate; oral

60.7

97.9

114

L04AD01

ATC

ciclosporin; systemic

33.2

96.9

128

R31

ICD-10 Finland

Unspecified haematuria

8.6

96.0

232

367

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

11.5

87.2

173

189

V03AE02

ATC

sevelamer; oral

188.3

81.9

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

113.0

75.5

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

127.4

75.5

TK820

NOMESCO Finland

Peritoneal dialysis

276.6

74.8

196

Kela drug reimbursment

Paricalcitol and cinacalcet

109.9

73.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

10.3

73.2

153

181

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

767.1

72.4

C02AC05

ATC

moxonidine; oral

13.2

72.2

132

119

B03XA01

ATC

erythropoietin; parenteral

45.0

71.6

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.9

67.2

462

2173

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.2

66.4

332

1178

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

109.9

65.1

L04AA01

ATC

[U] ciclosporin; systemic

30.9

62.0

N19

ICD-10 Finland

Unspecified kidney failure

15.9

59.3

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

72.0

58.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

25.7

57.6

C09CA01

ATC

losartan; oral

4.0

57.3

285

979

H05BX01

ATC

cinacalcet; oral

85.8

56.9

N17.9

ICD-10 Finland

Acute renal failure, unspecified

13.4

56.2

101

5828A

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]

+∞

53.8

321

Kela drug reimbursment

Paricalcitol and cinacalcet

98.6

50.5

R4110

NOMESCO Finland

Physiotherapy

3.6

50.1

301

1182

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.9

49.5

C07AG02

ATC

carvedilol; oral

7.6

49.1

122

186

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

8.5

48.8

112

151

N08.2*D69.0

ICD-10 Finland

Glomerular disorders in Henoch(-Schönlein) purpura

261.3

48.6

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

5.6

48.2

154

329

L04AX01

ATC

azathioprine; systemic

9.1

47.6

105

132

C08CA13

ATC

lercanidipine; oral

4.9

47.6

174

432

M10.9

ICD-10 Finland

Gout, unspecified

7.4

47.4

120

188

V03AE03

ATC

lanthanum carbonate; oral

130.6

46.3

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

127.8

45.3

Z3226

NOMESCO Finland

Physiotherapist

3.7

43.9

229

787

N08.2*D89.82

ICD-10 Finland

Nepropathy caused by deposition of the light chain of the immunoglobulins

+∞

43.1

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

59.3

43.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

5.5

42.0

135

287

C08CA02

ATC

felodipine; oral

5.2

41.4

139

311

I10

ICD-10 Finland

Essential (primary) hypertension

2.8

41.2

468

2732

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

35.5

41.2

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

43.5

39.9

Z2446

NOMESCO Finland

Social worker

5.8

39.7

121

241

K65.0

ICD-10 Finland

Acute peritonitis

27.5

39.5

U14

ICPC

Kidney symptom/complaint

24.6

38.9

D69.0

ICD-10 Finland

Allergic purpura

32.0

38.8

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

21.5

38.0

ZX120

NOMESCO Finland

Intravenous

4.9

37.9

134

315

C09CA06

ATC

candesartan; oral

3.3

36.9

230

889

3AC01

NOMESCO Finland

29.0

36.4

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

6.9

36.0

152

TPH04

NOMESCO Finland

Cathetrisation of vein

3.2

35.5

224

872

ZXE20

NOMESCO Finland

More than three and less than five hours

3.7

34.3

170

547

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

97.1

34.0

C02CA01

ATC

prazosin; oral

21.3

33.9

TK810

NOMESCO Finland

Hemofiltration

28.0

33.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.3

32.8

132

352

WW200

NOMESCO Finland

Immunization

9.1

32.4

58209

ICD-8 Finland

Chronic nephritis, Unspecified

91.6

32.0

RD210

NOMESCO Finland

13.0

32.0

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

9.4

31.3

C10AA05

ATC

atorvastatin; oral

2.6

31.2

329

1736

N082, D898

ICD-10 Finland

325.4

31.1

N05.9

ICD-10 Finland

Unspecified nephritic syndrome, unspecified

325.4

31.1

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

325.4

31.1

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

166.7

30.9

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

114.8

30.9

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

30.5

268

1271

M01AE01

ATC

ibuprofen; systemic, rectal

0.4

30.3

459

6070

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

+∞

29.4

N08.2*D57.8

ICD-10 Finland

Glomerular disorders in sickle-cell disorders

+∞

29.4

ZXE10

NOMESCO Finland

More than one and less than three hours

2.5

29.3

332

1807

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

83.4

29.0

R50.9

ICD-10 Finland

Fever, unspecified

3.4

28.9

159

550

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

107.5

28.9

Z2221

NOMESCO Finland

Medical doctor

2.6

28.2

271

1340

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.2

28.0

114

305

C02EA02

ATC

8.0

28.0

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

80.7

28.0

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.1

27.5

179

694

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.7

27.3

130

399

ZXA00

NOMESCO Finland

Right side

2.6

26.9

246

1176

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

26.6

167

631

Z3231

NOMESCO Finland

Registered nurse

2.6

26.4

255

1254

R4190

NOMESCO Finland

Nutritional therapy

6.7

26.3

112

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

62.3

26.1

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

62.3

26.1

XPX08

NOMESCO Finland

Intraoperative flow measurement

34.4

25.7

KBV00

NOMESCO Finland

Insertion of stent into ureter

29.6

25.6

WX203

NOMESCO Finland

Infraclavicular plexus blockade

9.3

25.2

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

60.1

25.2

H02AB06

ATC

prednisolone; systemic

2.3

25.0

383

2358

RS220

NOMESCO Finland

13.7

25.0

C07AB02

ATC

metoprolol; systemic

2.9

24.7

178

734

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

6.0

24.6

126

ZXA05

NOMESCO Finland

Left side

2.6

24.0

219

1034

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

10.6

23.1

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

41.5

22.8

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

86.1

22.8

B01AB10

ATC

tinzaparin; parenteral

4.4

22.7

214

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

24.8

22.3

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.2

22.3

357

2206

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

11.6

22.1

UKC02

NOMESCO Finland

Cystoscopy

2.8

21.9

156

632

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

5.3

21.9

141

N25.0

ICD-10 Finland

Renal osteodystrophy

82.5

21.8

L04AA05

ATC

[U] tacrolimus; systemic

118.4

21.7

ZXD05

NOMESCO Finland

Urgent procedure

2.2

21.7

281

1572

M05BA04

ATC

alendronic acid; oral

5.1

21.7

147

M10.3

ICD-10 Finland

Gout due to impairment of renal function

32.2

21.6

7151

FHL

Kidney transplantation

61.8

21.0

N08.2*D59.3

ICD-10 Finland

Glomerular disorders in haemolytic-uraemic syndrome

+∞

20.9

D89.8

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

+∞

20.9

N00.9

ICD-10 Finland

Acute nephritic syndrome, Unspecified

215.5

20.7

N02.9

ICD-10 Finland

Recurrent and persistent haematuria, unspecified

113.1

20.7

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

113.1

20.7

ZXE00

NOMESCO Finland

One hour or less

2.1

20.4

333

2047

ZXD10

NOMESCO Finland

Scheduled procedure

2.1

20.2

313

1881

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.6

20.1

169

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

20.1

230

1206

M10.0

ICD-10 Finland

Idiopathic gout

6.3

20.0

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

36.8

19.9

C10AA01

ATC

simvastatin; oral

2.1

19.7

314

1906

N03.0

ICD-10 Finland

Chronic nephritic syndrome, minor glomerular abnormality

107.8

19.6

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

41.2

19.6

C07AB07

ATC

bisoprolol; oral

2.1

19.5

343

2165

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

4.1

19.3

211

A02BC01

ATC

omeprazole; systemic

2.3

19.1

220

1151

JAL10

NOMESCO Finland

Laparotomy and removal of foreign body

+∞

18.8

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

71.7

18.8

7910X

ICD-9 Finland

Nonspecific findings on examination of urine, Proteinuria[PROTEINURIA NUD]

71.7

18.8

K06.18

ICD-10 Finland

Another gingival hyperplasia

71.7

18.8

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

102.5

18.6

I15.0

ICD-10 Finland

Renovascular hypertension

30.9

18.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.9

18.4

WX002

NOMESCO Finland

Sedation and analgesia

2.4

18.2

172

814

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

33.8

18.0

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

6.3

17.8

N082, D899

ICD-10 Finland

+∞

17.8

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

17.7

147

646

A46

ICD-10 Finland

Erysipelas

2.7

17.7

128

521

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.7

17.5

240

5997A

ICD-9 Finland

Other disorders of urethra and urinary tract, Haematuria

29.6

17.5

A10BH05

ATC

linagliptin; oral

4.9

17.4

126

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.6

17.3

248

212

Kela drug reimbursment

Gout

8.0

17.3

J01MA02

ATC

ciprofloxacin; systemic

2.0

17.1

299

1857

58399

ICD-8 Finland

Nephritis, unqualified

35.9

16.7

N06.9

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, unspecified

92.1

16.6

58200

ICD-8 Finland

Chronic nephritis, Cum uraemia

173.6

16.6

C08CA03

ATC

isradipine; systemic

10.7

16.3

WX892

NOMESCO Finland

Monitored bed care

3.4

16.3

255

WW500

NOMESCO Finland

Blood transfusion

5.2

16.3

104

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.9

15.8

102

383

H05BX02

ATC

paricalcitol; systemic

61.3

15.8

C10AA04

ATC

fluvastatin; oral

3.4

15.8

261

N08.2*D89.1

ICD-10 Finland

Glomerular disorders in cryoglobulinaemia

+∞

15.7

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

6.0

15.6

C09AA05

ATC

ramipril; oral

2.2

15.6

186

976

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.3

15.5

147

WX202

NOMESCO Finland

Supraclavicular plexus blockade

8.6

15.4

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.6

15.3

217

N02AX02

ATC

tramadol; systemic, rectal

1.9

15.2

330

2188

3025

Kela drug reimbursment

Calcium carbonate

20.5

15.2

H15.1

ICD-10 Finland

Episcleritis

8.5

14.9

78900

ICD-8 Finland

Abnormal urinary constituents of unspecified cause, Albuminuria

57.8

14.8

5839X

ICD-9 Finland

Nephritis and nephropathy, not specified as acute or chronic, With unspecified pathological lesion in kidney

81.7

14.6

U88

ICPC

Glomerulonephritis/nephrosis

152.7

14.5

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

19.6

14.3

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

14.2

173

912

K65.8

ICD-10 Finland

Other peritonitis

43.3

14.1

WX610

NOMESCO Finland

Patient controlled analgesia

14.8

14.1

A02BC02

ATC

pantoprazole; systemic

1.8

14.1

466

3533

M01AH05

ATC

etoricoxib; oral

0.5

14.0

228

3376

J01FF01

ATC

clindamycin; systemic

2.0

14.0

225

1329

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.9

14.0

265

1662

78930

ICD-8 Finland

Abnormal urinary constituents of unspecified cause, Haematuria

17.9

13.9

N02BE01

ATC

paracetamol; systemic, rectal

2.1

13.8

636

5399

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

13.7

142

694

J01CA04

ATC

amoxicillin; systemic

2.0

13.7

614

5141

M08.2

ICD-10 Finland

Juvenile arthritis with systemic onset

76.5

13.6

Z99.2

ICD-10 Finland

Dependence on renal dialysis

76.5

13.6

KAS96

NOMESCO Finland

Other transplantation of kidney or related procedure

+∞

13.6

N02.8

ICD-10 Finland

Recurrent and persistent haematuria, other

+∞

13.6

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

34.7

13.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.1

13.5

274

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

142.4

13.5

C09BA02

ATC

enalapril and diuretics; systemic

3.1

13.5

268

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.6

13.2

ZX108

NOMESCO Finland

Inhalation

15.4

13.1

J01MA12

ATC

levofloxacin; systemic

2.2

13.1

151

775

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.7

13.1

161

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

11.2

13.1

E87.5

ICD-10 Finland

Hyperkalaemia

9.6

13.0

M01AB05

ATC

diclofenac; systemic, rectal

0.6

12.8

293

3994

J01DB01

ATC

cefalexin; oral

2.0

12.7

625

5314

L01AA01

ATC

cyclophosphamide; systemic

71.0

12.6

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

12.6

171

937

M10

ICD-10 Finland

Gout

3.9

12.5

137

187

Kela drug reimbursment

MPA

132.0

12.5

TKA00

NOMESCO Finland

Needle biopsy of kidney or pelvis of kidney

132.0

12.5

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

132.0

12.5

WX402

NOMESCO Finland

General anaesthesia

2.2

12.3

143

736

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

18.4

12.1

C08CA05

ATC

nifedipine; systemic

3.3

12.1

195

C02DE10

ATC

9.5

12.0

WX204

NOMESCO Finland

Axillary plexus blockaced

4.6

12.0

RS221

NOMESCO Finland

7.2

11.9

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.6

11.8

154

B01AA03

ATC

warfarin; systemic

2.2

11.8

136

696

C03AA03

ATC

hydrochlorothiazide; oral

2.9

11.8

275

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

66.0

11.6

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

66.0

11.6

306

Kela drug reimbursment

Erythropoietin and darbepoetin

23.3

11.6

KBV10

NOMESCO Finland

Removal of stent from ureter

11.3

11.6

L57.0

ICD-10 Finland

Actinic keratosis

3.0

11.5

230

5828B

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,NEFR SDR]

+∞

11.5

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

+∞

11.5

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.2

11.5

107

4059B

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]

121.7

11.5

5829A

ICD-9 Finland

Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]

121.7

11.5

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.5

11.3

383

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.8

11.2

283

RS222

NOMESCO Finland

7.2

11.1

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

10.2

11.0

E0000UV

ATC

1.7

11.0

283

1934

L01BB01

ATC

44.0

10.9

5AB14

NOMESCO Finland

44.0

10.9

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

9.0

10.8

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

10.8

105

496

B01AB04

ATC

dalteparin; parenteral

3.7

10.8

134

WW400

NOMESCO Finland

Plasmaferesis

28.5

10.7

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

10.7

165

947

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

13.1

10.7

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

60.8

10.6

XF402

NOMESCO Finland

ECG with work load test

2.4

10.6

411

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

111.4

10.4

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

111.4

10.4

K65.9

ICD-10 Finland

Peritonitis, unspecified

33.0

10.4

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.3

10.3

161

N17.8

ICD-10 Finland

Other acute renal failure

9.0

10.3

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

7.6

10.2

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

10.2

300

B01AC04

ATC

clopidogrel; oral

2.1

10.2

116

589

A12BA01

ATC

potassium chloride; oral

4.3

10.1

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.2

10.1

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.6

10.1

294

D64.9

ICD-10 Finland

Anaemia, unspecified

2.6

10.0

303

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

5.7

10.0

E83.51

ICD-10 Finland

Hypocalcemia

14.8

10.0

M31.3

ICD-10 Finland

Wegener granulomatosis

40.6

10.0

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.2

9.9

166

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

26.4

9.8

C08DB01

ATC

diltiazem; oral

3.7

9.8

114

5820A

ICD-9 Finland

Chronic glomerulonephritis, With lesion of proliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA PROLIF,EI NEFR SDR]

55.7

9.7

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

15.3

9.5

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.8

9.5

224

TK830

NOMESCO Finland

Ultrafiltration

101.2

9.4

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

17.8

9.4

D89.9

ICD-10 Finland

Disorder involving the immune mechanism, unspecified

+∞

9.4

TK823

NOMESCO Finland

Peritoneal permeability analysis

+∞

9.4

N08.2*D65

ICD-10 Finland

Glomerular disorders in disseminated intravascular coagulation [defibrination syndrome]

+∞

9.4

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.9

9.3

207

GD1LA

NOMESCO Finland

6.8

9.2

UJF32

NOMESCO Finland

Coloscopy

1.8

9.1

174

1072

GD1AD

NOMESCO Finland

Thorax CT examination

3.4

9.0

133

J01MA14

ATC

moxifloxacin; systemic

2.4

9.0

346

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

9.0

290

2082

UJF92

NOMESCO Finland

Capsular endoscopy

5.6

9.0

A41.9

ICD-10 Finland

Sepsis, unspecified

3.9

8.9

BBA50

NOMESCO Finland

Total parathyroidectomy

50.6

8.7

40399

ICD-8 Finland

Hypertensive renal disease

50.6

8.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.5

8.7

276

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

8.6

397

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

11.7

8.6

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

16.5

8.6

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

8.5

116

630

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

5.2

8.5

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.5

8.5

112

ECA35

NOMESCO Finland

Complicated excision of lesion of gingiva

27.8

8.5

KH1EE

NOMESCO Finland

Urologic ultrasound examination

20.3

8.5

B07.9

ICD-10 Finland

Verruca simplex

3.6

8.5

107

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.0

8.4

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

8.4

106

560

B05D

ATC

PERITONEAL DIALYTICS

91.0

8.4

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

12.9

8.4

WX110

NOMESCO Finland

Local anesthesy

1.6

8.4

509

4249

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

8.4

124

695

N082, D890

ICD-10 Finland

+∞

8.3

N082, Z940

ICD-10 Finland

+∞

8.3

N082, D8989

ICD-10 Finland

+∞

8.3

N04.89

ICD-10 Finland

Nephrotic syndrome, other

+∞

8.3

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

8.2

339

M13.9

ICD-10 Finland

Arthritis, unspecified

2.5

8.2

266

T92

ICPC

Gout

4.9

8.1

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

17.4

8.1

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

22.3

8.0

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.3

8.0

118

C09CA07

ATC

telmisartan; oral

2.6

8.0

237

K05.30

ICD-10 Finland

Periodontitis complex

2.1

7.9

498

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.5

7.9

268

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.6

7.8

221

K05.11

ICD-10 Finland

Gingivitis (chronic) hyperplastic

45.4

7.7

ZX197

NOMESCO Finland

45.4

7.7

SPAT1262

SPAT

Handing over of treatment supplies

1.8

7.7

137

820

J01CF05

ATC

flucloxacillin; systemic

3.2

7.6

128

A41.8

ICD-10 Finland

Other specified sepsis

6.8

7.6

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.3

7.6

336

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

25.3

7.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

7.6

146

898

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.8

7.6

170

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.6

7.6

Z3229

NOMESCO Finland

Other healthcare associate professional

2.3

7.5

305

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

6.6

7.4

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.6

7.4

I12.9

ICD-10 Finland

Hypertensive renal disease without renal failure

80.8

7.4

KAS40

NOMESCO Finland

Excision of transplanted kidney

80.8

7.4

SCB02

NOMESCO Finland

Training for mouth care at home

80.8

7.4

L95.8

ICD-10 Finland

Other vasculitis limited to skin

80.8

7.4

O12.1

ICD-10 Finland

Gestational proteinuria

13.5

7.4

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

7.4

210

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.6

7.3

H02AB07

ATC

prednisone; oral

2.0

7.3

530

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.3

7.3

293

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

11.0

7.3

4AA09

NOMESCO Finland

+∞

7.3

5829B

ICD-9 Finland

Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,NEFR SDR]

+∞

7.3

5809A

ICD-9 Finland

Acute glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS ACUTA NUD,EI NEFR SDR]

+∞

7.3

D89.0

ICD-10 Finland

Polyclonal hypergammaglobulinaemia

+∞

7.3

6119

FHL

Other measure in this category

+∞

7.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

7.3

296

E21.2

ICD-10 Finland

Other hyperparathyroidism

15.9

7.2

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

7.2

380

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.8

7.2

163

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

7.2

217

XF612

NOMESCO Finland

Measurement of central venous pressure

20.2

7.1

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

20.2

7.1

M04AA03

ATC

febuxostat; oral

12.2

7.1

288

Kela drug reimbursment

Febuxostat

12.2

7.1

I50.0

ICD-10 Finland

Congestive heart failure

2.9

7.1

146

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.6

7.1

A06AD11

ATC

lactulose; oral

2.1

7.1

420

C07AG01

ATC

labetalol; systemic

7.1

7.0

K05.31

ICD-10 Finland

Periodontitis pronounced

2.2

7.0

357

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

5.9

6.9

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

13.9

6.9

J05AB11

ATC

valaciclovir; oral

2.0

6.9

491

WZC30

NOMESCO Finland

Teaching

1.9

6.9

541

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.9

6.9

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.7

6.9

174

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

6.8

204

1415

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.2

6.8

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.1

6.8

Z94.4

ICD-10 Finland

Liver transplant status

16.9

6.8

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

16.9

6.8

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

6.7

128

782

C10AA03

ATC

pravastatin; oral

2.5

6.7

196

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.4

6.7

227

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

22.7

6.7

C10AX09

ATC

ezetimibe; oral

2.0

6.7

435

B02.9

ICD-10 Finland

Zoster without complication

3.0

6.7

133

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.2

6.7

WX882

NOMESCO Finland

High dependency care

4.3

6.7

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

7.9

6.6

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

6.6

147

942

SPAT1255

SPAT

Intravenous administration of medicine

2.5

6.6

210

JN4AD

NOMESCO Finland

Body CT examination

2.3

6.6

250

SCD01

NOMESCO Finland

Simple removal of tooth plaque or tartar

8.8

6.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

6.5

446

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

5.1

6.5

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.6

6.5

174

1172

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

70.4

6.4

58199

ICD-8 Finland

Nephrotic syndrome

70.4

6.4

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.1

6.4

110

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.4

6.4

238

58099

ICD-8 Finland

Acute nephritis

14.4

6.4

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

14.4

6.4

TPX15

NOMESCO Finland

Removal of vascular injection port

14.4

6.4

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

6.4

219

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

5.0

6.4

C09DA01

ATC

losartan and diuretics; oral

2.1

6.4

359

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.2

6.3

287

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

6.3

141

901

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

11.1

6.3

RJ420

NOMESCO Finland

11.1

6.3

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

11.1

6.3

H26.3

ICD-10 Finland

Drug-induced cataract

11.1

6.3

7101

FHL

Needle biopsy in the operating room

+∞

6.3

4059A

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA RENOVASCULARIS]

+∞

6.3

N06.3

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, diffuse mesangial proliferative glomerulonephritis

+∞

6.3

N00.3

ICD-10 Finland

Acute nephritic syndrome, Diffuse mesangial proliferative glomerulonephritis

+∞

6.3

N0839, D8980

ICD-10 Finland

+∞

6.3

N03.5

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis

+∞

6.3

D59.3

ICD-10 Finland

Haemolytic-uraemic syndrome

+∞

6.3

K02.9

ICD-10 Finland

Dental caries, unspecified

4.8

6.3

R60.0

ICD-10 Finland

Localized oedema

2.0

6.2

369

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

5.4

6.2

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

6.2

347

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

6.2

178

1221

XQ848

NOMESCO Finland

Dermatological photography

4.3

6.2

C02DE02

ATC

7.8

6.1

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

6.1

168

1137

HA1AA

NOMESCO Finland

X-ray mammography

2.8

6.1

138

EB1WA

NOMESCO Finland

8.7

6.1

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.6

6.1

174

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.2

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020779) Urea [Moles/volume] in Serum or Plasma

589

617

27.92

307.65

21.7

8.2

mmol/l

13.3

9.1

24.92

578

587

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

527

433

29.69

307.65

12.2

4.2

ng/l

154.7

85.3

17.42

500

388

(40768446) Kidney Pathology biopsy report

255

156.95

307.65

1.7

1.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

326

213

23.99

307.65

6.1

2.8

mg/l

1.9

1.5

4.97

320

198

(3003458) Phosphate [Moles/volume] in Serum or Plasma

654

878

27.63

307.65

23.3

6.4

mmol/l

1.1

1.0

13.12

641

824

(3012516) Albumin [Mass/volume] in Urine

699

1961

14.49

287.86

10.1

3.3

mg/l

372.2

281.3

0.33

659

1308

(3020682) Albumin/Creatinine [Ratio] in Urine

712

2067

14.97

283.13

12.1

4.0

mg/mmol

41.5

9.6

22.90

671

1362

(3042733) HLA Ab [Presence] in Serum

149

69.06

270.56

6.5

5.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

229

160

19.12

264.36

9.3

6.6

iu/ml

3739.6

303.0

0.71

(3009508) Creatinine [Moles/volume] in Urine

708

2176

13.55

261.15

10.2

3.3

mmol/l

7.0

8.4

15.92

686

1824

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

451

885

9.58

249.44

9.4

2.5

24.5

24.3

0.12

411

762

(3004789) Transferrin [Mass/volume] in Serum or Plasma

457

951

9.09

238.06

9.0

2.5

g/l

2.0

2.3

28.50

447

890

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

707

2416

11.66

225.51

11.8

3.0

—

(3000850) Epithelial cells [#/volume] in Urine

531

1376

8.43

221.51

7.4

2.4

e6/l

2.5

5.1

3.66

502

1217

(3022948) Iron [Moles/volume] in Serum or Plasma

458

1025

8.39

220.23

9.1

2.5

umol/l

12.5

14.0

4.78

449

949

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

196

157

15.86

208.02

2.9

1.4

u/ml

112.8

104.4

0.56

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

260

322

11.12

206.85

14.0

3.9

mmol/l

22.8

24.1

6.88

250

294

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

196

165

15.08

201.82

2.9

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

619

2015

8.33

199.94

9.9

3.0

e6/l

68.6

88.0

0.25

559

1563

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

104

90.82

197.66

5.0

4.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

716

2782

10.24

189.50

17.5

5.2

g/l

34.8

35.9

7.74

702

2619

(3030467) Casts [#/volume] in Urine by Automated count

576

1843

7.39

185.87

9.5

2.9

e6/l

0.2

0.4

4.54

499

1394

(36304419) Bacteria [Presence] in Urine

568

1795

7.33

185.71

9.1

2.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

567

1822

7.16

180.89

5.7

2.7

umol/l

978.5

6322.7

4.26

544

1612

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

146

19.77

179.22

1.1

1.2

—

(3002032) Base excess in Venous blood by calculation

324

611

7.89

178.87

14.5

3.7

mmol/l

-0.0

1.8

12.81

277

486

(3018095) Leukocytes [#/volume] in Urine

643

2344

7.84

178.17

12.1

3.4

e6/l

22.6

85.8

2.25

573

1682

(3021447) Carbon dioxide [Partial pressure] in Venous blood

323

616

7.78

176.18

14.5

3.7

kpa

5.8

0.08

318

602

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

147

18.85

176.16

2.1

2.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

183

172

13.23

175.07

1.8

1.2

u/ml

260.5

260.8

0.00

143

105

(3018418) pH of Serum or Plasma

565

1866

6.87

172.98

23.2

4.3

7.4

6.65

115

371

(3009445) Proteinase 3 Ab [Units/volume] in Serum

227

297

10.01

171.34

1.9

1.4

u/ml

42.6

10.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

221

283

10.15

169.54

2.9

2.1

g/l

1.4

1.5

0.88

200

242

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

183

181

12.56

169.10

1.7

1.2

—

(3026782) Osmolality of Urine

455

1311

6.23

159.47

8.2

2.6

mosm/kgh2o

502.1

577.8

13.65

424

1122

(3000991) Gas panel - Venous blood

297

574

7.36

158.39

17.4

9.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

45.20

155.54

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

41.57

152.29

1.1

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

676

2878

7.22

148.27

28.1

6.7

mmol/l

1.2

8.89

663

2628

(3018677) aPTT in Platelet poor plasma by Coagulation assay

389

1034

6.03

147.37

3.0

2.2

29.3

29.6

0.45

382

1004

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

404

1113

5.94

146.92

6.0

2.6

e6/l

0.5

1.0

2.70

275

641

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

708

3161

7.90

146.60

34.6

7.4

mmol/l

1.2

2.43

637

2686

(3024932) HLA-DR beta [Type]

35.39

144.04

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

113

20.49

143.15

1.5

1.2

—

(3024471) HLA-A [Type]

34.21

142.57

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

136

111

14.36

141.07

9.7

3.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

627

2585

6.21

139.84

4.4

2.2

nmol/l

74.3

74.5

0.07

617

2340

(3048929) Epstein Barr virus Ab [Presence] in Serum

195

272

8.97

138.30

1.6

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

259

512

6.80

133.16

8.6

2.9

kpa

6.7

4.7

11.40

252

500

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

261

521

6.75

132.85

4.1

2.5

ml/min/173m2

41.5

70.4

19.55

123

210

(3024928) Oxygen saturation in Venous blood

139

143

11.39

123.79

8.5

3.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

363

1051

5.24

120.98

6.6

2.8

e6/l

1.4

0.03

230

582

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

163

215

9.11

120.33

1.6

1.5

g/l

0.3

0.2

3.17

151

206

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

166

225

8.90

119.83

1.6

1.5

g/l

1.2

0.22

155

216

(3017143) Hepatitis C virus Ab [Presence] in Serum

335

934

5.23

116.23

4.2

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

30.10

114.89

3.1

2.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

155

206

8.95

113.48

4.2

3.0

u/ml

0.3

0.77

112

(3014148) Varicella zoster virus Ab [Titer] in Serum

109

13.57

110.92

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

359

1095

4.90

110.75

4.4

3.6

mmol/l

0.8

1.13

347

1037

(3011648) Oxygen content in Venous blood

18.26

107.78

5.8

2.1

11.3

10.3

0.86

(3037121) Protein [Mass/volume] in Urine

158

235

8.01

104.86

6.7

4.1

g/l

0.8

0.2

2.35

124

118

(3020630) Protein [Mass/volume] in Serum or Plasma

229

503

5.84

103.45

2.1

2.9

g/l

65.1

67.3

3.25

216

460

(42870588) Differential panel, method unspecified - Blood

535

2324

4.43

100.59

9.0

5.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

105

100

11.82

98.00

1.2

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

14.92

96.83

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

353

1170

4.41

95.56

4.0

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

643

3276

4.78

94.96

9.4

3.2

estimate

0.0

0.00

154

637

(3009261) Glucose [Presence] in Urine by Test strip

648

3321

4.82

94.92

9.4

3.2

estimate

0.0

0.14

157

613

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

270

736

4.88

94.02

4.3

4.5

u/l

237.1

238.1

0.05

262

698

(3021601) Nitrite [Presence] in Urine by Test strip

641

3275

4.72

93.85

12.9

4.4

estimate

0.0

0.50

161

655

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

147

235

7.33

90.94

1.7

1.6

titre

172.9

222.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

257

690

4.88

90.91

4.3

3.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

192

402

5.86

90.62

1.6

2.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

154

260

6.99

90.49

2.4

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

252

688

4.76

86.93

4.1

2.9

2.0

1.8

1.27

243

623

(3011397) Hemoglobin [Presence] in Urine by Test strip

386

1459

3.98

85.22

8.4

3.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

14.12

84.69

1.3

2.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

762

4660

6.43

82.91

13.3

3.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

582

2935

4.02

82.71

8.4

2.7

ug/l

195.3

138.7

7.57

573

2730

(3023520) Reticulocytes [#/volume] in Blood

207

509

5.03

80.75

3.8

3.0

e9/l

70.7

73.3

0.38

145

398

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

125

194

7.37

79.11

1.9

3.7

mg/l

55.2

34.4

3.22

156

(3034860) Kappa light chains.free [Mass/volume] in Serum

125

194

7.37

79.11

1.9

3.7

mg/l

72.5

89.4

0.21

154

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

123

192

7.30

77.38

1.9

3.7

ratio

1.3

1.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

156

318

5.77

75.09

8.9

2.6

0.7

0.07

156

309

(3021879) Hepatitis B virus core Ab [Presence] in Serum

218

594

4.57

74.41

2.5

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

707

4261

4.65

73.43

8.2

3.9

e6/l

6.7

251.1

—

(1616796) Gas panel - Central venous blood

106

150

7.92

72.68

8.8

3.2

—

(3033658) Prothrombin time (PT) actual/Normal

405

1734

3.52

71.31

7.8

4.0

99.3

90.6

7.61

396

1701

(3001604) Monocytes [#/volume] in Blood

618

3461

3.77

70.08

10.2

5.9

e9/l

0.6

5.64

564

3012

(46235355) HIV 1 and 2 tests - Meaningful Use set

364

1471

3.55

70.01

4.1

1.9

—

(3006315) Basophils [#/volume] in Blood

618

3473

3.75

69.42

10.3

5.9

e9/l

0.0

0.33

565

3030

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

91.22

68.19

12.0

3.2

mmol/l

5.5

7.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

183

464

4.74

68.01

8.0

3.3

kpa

5.0

5.2

3.17

176

435

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

177

438

4.83

67.78

7.6

3.4

mmol/l

0.3

1.6

3.80

126

326

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

104

156

7.44

67.61

2.0

1.2

—

(3009343) pH of Capillary blood

181

458

4.74

67.40

7.8

3.3

7.4

0.69

(3013115) Eosinophils [#/volume] in Blood

624

3585

3.67

66.40

10.8

6.3

e9/l

0.2

1.83

574

3185

(3019198) Lymphocytes [#/volume] in Blood

622

3568

3.66

66.32

10.4

6.0

e9/l

1.8

2.0

1.26

566

3179

(3023368) Bacteria identified in Blood by Culture

405

1814

3.32

64.87

7.7

4.5

—

(3019069) Monocytes/100 leukocytes in Blood

588

3286

3.48

64.78

11.1

6.3

8.8

8.7

0.34

581

3106

(3022096) Basophils/100 leukocytes in Blood

574

3164

3.43

64.65

11.1

6.0

0.6

0.7

1.42

569

2978

(3006504) Eosinophils/100 leukocytes in Blood

585

3269

3.45

64.25

10.9

6.0

2.9

0.29

580

3070

(3042936) Bacteria identified in Isolate by Culture

283

1034

3.58

62.70

2.6

2.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

206

607

4.14

62.53

12.3

8.4

mmol/l

1.1

1.4

3.99

201

589

(3015377) Calcium [Moles/volume] in Serum or Plasma

436

2076

3.22

62.35

7.5

3.4

mmol/l

2.3

1.74

416

1844

(3002030) Lymphocytes/100 leukocytes in Blood

593

3382

3.41

62.08

10.9

6.0

25.2

28.1

9.71

585

3181

(3016750) Collection duration of Urine

13.40

61.17

3.8

2.4

min

507.2

497.5

0.25

(3018010) Neutrophils/100 leukocytes in Blood

585

3330

3.35

61.00

10.6

5.9

60.0

57.0

8.84

578

3148

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

120

7.95

60.76

1.8

1.5

—

(3032080) INR in Blood by Coagulation assay

508

2692

3.16

59.42

17.1

8.5

inr

1.2

0.42

156

813

(3015235) Bicarbonate [Moles/volume] in Capillary blood

101

175

6.40

57.06

5.3

2.5

mmol/l

22.6

24.7

4.00

154

(40760888) Immunoglobulin light chains.free panel - Serum

145

6.98

56.95

1.7

3.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

642

3986

3.38

55.29

12.2

9.4

e9/l

4.6

4.1

6.54

592

3493

(40758558) Short blood count panel - Blood

365

1660

3.08

54.98

8.1

6.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

108

212

5.68

53.53

1.7

2.6

g/l

10.1

10.5

0.38

183

(3004775) Volume in Urine collected for unspecified duration

10.50

53.03

3.7

2.3

841.3

666.6

1.47

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

754

5257

4.44

52.37

17.7

7.8

u/l

77.2

77.7

0.15

746

4975

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

232

5.34

51.28

1.7

2.5

g/l

7.3

7.2

0.14

177

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

232

5.34

51.28

1.7

2.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

232

5.34

51.28

1.7

2.5

g/l

4.5

3.9

3.13

168

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

165

6.20

51.19

1.8

2.8

g/l

0.0

0.00

154

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

217

5.49

51.12

1.7

2.6

g/l

3.2

3.1

0.29

171

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

166

6.16

50.87

1.8

2.8

g/l

0.0

0.49

154

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

178

5.87

49.39

1.8

2.8

g/l

0.0

0.49

166

(3021589) Normoblasts [#/volume] in Blood

530

3071

2.88

49.31

20.4

9.4

e9/l

0.0

0.47

419

2517

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

261

1042

3.16

48.43

2.3

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

205

722

3.41

46.66

2.1

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

199

5.43

46.65

1.7

2.9

g/l

0.1

1.2

2.54

179

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

184

5.61

46.58

1.8

2.6

g/l

35.5

38.3

3.27

159

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

203

723

3.36

45.27

2.2

1.9

—

(3037522) Nuclear Ab [Titer] in Serum

241

951

3.13

45.27

1.4

1.3

titre

547.3

433.3

0.30

191

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

334

1578

2.82

45.13

3.1

2.0

mg/l

3.0

0.19

304

1346

(40761535) Cells panel - Urine sediment

167

527

3.69

44.93

10.7

3.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

342

1657

2.76

43.75

3.6

2.3

—

(3044640) Blood type and Crossmatch panel - Blood

400

2138

2.62

41.48

4.0

2.4

—

(3021901) Oxygen saturation in Capillary blood

125

6.19

40.35

5.2

2.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

251

1076

2.88

40.05

2.0

1.7

nmol/l

1252.5

1173.8

0.56

221

831

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

146

455

3.66

39.76

1.8

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

212

837

3.03

39.20

2.6

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

193

5.03

39.17

4.7

2.3

ug/min

454.4

110.2

2.54

109

(3012501) Base excess in Blood by calculation

156

5.40

37.61

9.4

4.3

mmol/l

1.8

2.2

0.78

105

(3036603) Volume of Urine

9.29

37.48

2.0

1.5

1949.0

1726.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

172

5.09

36.48

1.5

1.2

—

(3025315) Body weight

67.93

34.28

5.0

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

542

3540

2.43

33.98

6.8

6.7

umol/l

10.1

11.7

2.72

526

3378

(3022313) Gas panel - Capillary blood

115

338

3.77

33.93

8.3

3.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

290

1445

2.52

33.36

2.0

1.5

nmol/l

17.1

19.8

2.77

273

1233

(3026008) Bacteria identified in Urine by Culture

312

1612

2.47

33.14

3.5

2.7

—

(40767503) Oxygen content in Capillary blood by calculation

144

5.20

32.64

5.2

2.6

16.3

16.2

0.07

(3013826) Glucose [Moles/volume] in Serum or Plasma

589

4033

2.45

32.57

13.9

5.1

mmol/l

6.7

0.01

580

3784

(3006184) Hemoglobin [Mass/volume] in Capillary blood

142

5.19

32.15

4.3

2.2

g/l

124.8

130.5

0.95

(3029937) Albumin [Presence] in Urine by Test strip

328

1754

2.40

32.06

10.9

3.4

estimate

0.1

0.0

1.01

122

624

(3037756) Immunofixation for Serum or Plasma

132

5.33

31.75

1.3

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

10.37

30.21

1.0

miu/ml

1559.0

1588.6

0.04

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

100

5.69

28.21

1.6

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

162

654

2.82

28.01

3.0

2.5

u/l

39.6

107.5

0.47

152

574

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

418

2585

2.20

27.87

10.3

3.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

412

2543

2.19

27.49

2.3

1.9

pmol/l

102.9

94.7

2.55

230

1412

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

173

4.38

26.94

1.5

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

174

4.36

26.74

1.6

1.9

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

298

3.54

26.62

9.0

3.8

mmol/l

23.4

24.8

6.13

282

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

363

2153

2.18

26.56

4.0

2.7

u/l

63.5

57.1

2.79

356

2013

(3049717) Cytology report of Urine Cyto stain

284

3.59

26.45

2.3

2.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

5.58

26.17

8.1

6.3

mg/l

12.0

10.5

1.48

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

6.89

26.13

1.3

1.1

titre

90.0

197.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

123

4.98

26.06

1.5

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

114

394

3.18

25.89

1.9

1.4

—

(4035726)

139

554

2.80

24.43

1.6

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

148

4.44

24.13

1.4

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

198

3.94

23.98

4.0

3.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

232

3.70

23.88

2.3

2.0

97.5

90.4

1.57

220

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

223

3.75

23.77

1.8

1.6

iu/ml

1.3

0.0

0.56

(3044927) Protein electrophoresis panel - Urine

6.58

23.25

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

215

3.73

22.76

1.5

2.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

320

1895

2.09

22.69

8.5

2.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

5.68

22.14

1.7

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

318

1894

2.08

22.08

2.2

1.6

mmol/l

1.6

1.4

1.53

297

1601

(40761536) Microorganisms panel - Urine sediment

140

592

2.63

21.79

13.7

3.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

130

4.45

21.66

3.7

3.4

e9/l

4.5

4.4

0.08

130

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

772

6456

2.86

21.03

10.3

5.5

mmol/mol

39.0

39.7

1.70

753

6046

(3019550) Sodium [Moles/volume] in Serum or Plasma

825

7171

4.42

20.93

52.5

15.2

mmol/l

139.4

139.7

2.87

820

6990

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

135

4.28

20.64

4.2

3.8

59.6

56.4

1.08

135

(3003396) Base excess in Arterial blood by calculation

164

766

2.41

20.60

10.2

9.5

mmol/l

-0.8

1.0

5.72

138

608

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

6.69

20.59

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

104

388

2.91

20.53

10.8

13.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

464

3215

1.96

20.50

5.6

4.0

—

(3036489) Thrombin time

268

3.28

20.32

2.4

1.9

23.4

21.4

1.53

238

(3023103) Potassium [Moles/volume] in Serum or Plasma

825

7196

4.33

20.27

55.2

15.3

mmol/l

4.2

4.0

45.52

820

7008

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

49.27

20.24

4.1

3.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

155

715

2.42

19.98

2.7

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

322

3.04

19.72

1.6

2.1

u/l

36.1

38.1

0.41

290

(3005719) IgG [Mass/volume] in Serum or Plasma

134

582

2.54

19.64

2.4

2.2

g/l

10.1

10.7

0.89

122

534

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

5.83

19.59

1.2

u/l

62.4

54.3

0.36

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

100

379

2.85

19.15

1.9

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

644

5061

2.07

19.06

6.3

3.8

mm/h

21.8

10.7

33.45

617

4704

(3017704) Immunofixation for Urine

7.20

18.75

1.1

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

209

3.45

18.55

2.2

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

321

2014

1.95

18.54

2.3

2.1

u/l

151.0

271.6

1.72

308

1907

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

782

6683

2.81

18.49

38.6

12.0

ml/min/173m2

53.8

85.5

117.10

733

5533

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

812

7092

3.45

18.21

41.8

13.4

mg/l

19.3

23.9

5.63

737

5579

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

122

4.11

17.20

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

122

4.11

17.20

1.4

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

275

3.02

16.98

2.4

2.1

ug/l

2.3

2.5

0.05

248

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

145

3.75

16.40

1.2

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

40.93

16.38

2.3

5.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

107

457

2.53

16.13

1.7

1.6

g/l

1.1

1.4

1.02

100

422

(3017181) Myelocytes/100 leukocytes in Blood

128

594

2.36

16.10

6.1

4.4

0.7

0.9

0.30

182

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

4.41

15.86

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

118

537

2.39

15.49

5.8

4.3

0.5

0.4

0.24

130

(3021440) Promyelocytes/100 leukocytes in Blood

121

557

2.36

15.48

6.2

4.5

0.1

0.47

164

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

4.32

15.45

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

12.70

15.17

1.7

1.1

—

(3025159) Blasts/100 leukocytes in Blood

115

523

2.38

15.10

6.1

4.6

0.0

0.2

1.48

138

(3036481) Cortisol [Moles/volume] in Serum or Plasma

133

646

2.25

14.99

2.4

2.0

nmol/l

348.3

368.3

0.62

120

604

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

781

6825

2.52

14.79

6.8

3.8

mmol/l

1.5

1.3

6.82

759

6347

(3003694) ABO and Rh group [Type] in Blood

309

2047

1.79

14.19

1.7

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

24.24

13.83

2.6

1.5

ng/l

211.6

99.9

—

(3047189) Immunofixation for 24 hour Urine

6.92

13.63

1.2

1.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

794

7056

2.57

13.32

7.5

4.2

mmol/l

1.3

1.4

8.86

773

6571

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

348

2430

1.72

13.03

3.9

3.5

u/l

29.2

33.3

2.69

333

2318

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

125

3.57

12.78

1.1

1.2

u/ml

6.4

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

795

7094

2.53

12.76

7.7

4.2

mmol/l

4.4

4.6

13.52

775

6642

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

198

3.01

12.73

1.6

2.2

mg/l

18.0

11.4

3.10

182

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

11.98

12.66

3.8

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

252

1620

1.78

12.53

8.0

4.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

5.12

12.48

1.4

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

801

7189

2.59

12.38

7.9

4.6

mmol/l

2.5

2.8

17.65

780

6690

(3044889) 12 lead EKG panel

593

4822

1.73

12.31

4.5

3.6

—

(3045414) Leukocytes [Presence] in Urine

278

2.65

12.20

3.5

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

699

5980

1.89

12.03

51.3

16.1

14.0

13.6

8.23

692

5868

(3019150) Specific gravity of Urine by Refractometry

228

1448

1.78

11.70

10.4

3.4

kg/l

1.0

0.00

199

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

118

3.51

11.64

1.5

1.2

u/ml

3.9

6.4

0.48

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

182

1084

1.86

11.51

3.4

3.1

mmol/l

2.5

2.4

2.15

164

962

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

168

3.03

11.20

1.2

u/ml

7.3

2.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

3.72

11.16

1.5

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

170

3.00

10.98

1.2

u/ml

3.9

11.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.64

10.84

1.5

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

221

1418

1.75

10.84

1.6

1.3

g/l

3.7

2.5

9.11

159

920

(3019225) pH of Specimen

117

616

2.04

10.59

17.0

4.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

4.90

10.53

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

4.90

10.53

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

4.90

10.53

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.99

10.30

1.6

1.8

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

4.80

10.29

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

4.80

10.29

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

4.80

10.29

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

4.04

10.10

2.4

2.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

115

3.32

9.96

1.5

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.99

9.92

1.3

2.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

26.35

9.83

6.2

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

26.35

9.83

1.2

—

(3051651) Icteric interference index of Serum or Plasma

4.61

9.82

3.8

4.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

132

3.13

9.77

1.5

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

3.81

9.66

1.3

2.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

146

2.97

9.40

1.4

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

188

2.70

9.16

1.8

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

5.09

9.12

1.7

1.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

5.09

9.12

1.7

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

226

2.53

8.97

1.8

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

6.09

8.67

1.8

1.6

—

(3045424) Erythrocytes [Presence] in Urine

120

3.09

8.67

1.6

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

5.09

8.64

1.6

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

5.09

8.64

1.6

1.8

—

(40768443) Skin Pathology biopsy report

268

2.37

8.63

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

578

4871

1.57

8.52

3.3

3.1

—

(3012441) Differential panel - Pleural fluid

3.95

8.46

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

818

7598

2.47

8.44

25.0

10.0

u/l

24.9

29.1

16.67

810

7376

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

228

2.46

8.33

2.2

3.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

3.89

8.29

2.0

—

(4268621)

3.54

8.15

2.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

3.50

8.00

1.5

2.3

30.9

33.5

1.97

(3035880) pH of Pleural fluid

5.24

7.95

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

3.71

7.78

1.5

1.4

e6/l

789.3

1846.5

1.62

(3051611) Lipemic interference index of Serum or Plasma

3.71

7.78

3.7

4.4

—

(3021788) Differential panel - Synovial fluid

118

2.96

7.66

1.9

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

188

1256

1.64

7.64

5.2

3.6

ng/l

153.3

544.5

2.39

157

928

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

113

3.00

7.61

1.5

1.2

u/ml

2.6

5.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

220

1532

1.59

7.53

2.8

1.7

mg/l

1.7

1.1

1.61

184

1157

(3024980) IgG subclass 4 [Mass/volume] in Serum

114

2.97

7.50

1.3

1.8

g/l

0.7

0.9

0.30

(3020891) Body temperature

259

2.29

7.49

8.2

4.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

109

3.01

7.45

3.0

2.3

—

1330.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

+∞

7.30

5.6

0.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

126

765

1.76

7.29

36.5

20.7

inr

1.4

1.3

0.20

112

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

4.78

7.18

2.3

1.5

u/field

22.4

0.7

1.54

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

6.95

7.16

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

438

1.96

7.10

1.3

u/ml

217.4

257.6

0.23

407

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

111

658

1.79

6.96

3.0

2.4

g/l

0.2

0.05

106

616

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

6.07

6.92

6.1

8.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

6.07

6.92

1.1

1.4

—

(40761511) CBC panel - Blood by Automated count

803

7481

2.06

6.92

38.8

12.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

4.32

6.77

1.1

iu/ml

304.7

237.5

0.29

(44790048)

3.10

6.66

1.3

1.7

—

(44790047)

3.10

6.66

1.3

1.7

—

(44806118)

3.10

6.66

1.3

1.7

—

(44790049)

3.10

6.66

1.3

1.7

—

(3016330) Potassium [Moles/time] in 24 hour Urine

18.17

6.27

1.8

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

+∞

6.26

3.3

0.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

6.31

5.96

1.4

1.3

—

(3019060) Gas panel - Arterial blood

436

1.87

5.92

8.0

6.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.22

5.84

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.22

5.84

1.5

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

3.06

5.84

1.8

1.6

49.9

62.2

0.53

(3028679) Herpes simplex virus Ab [Presence] in Serum

4.43

5.78

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

3.39

5.75

1.4

e6/l

21308.1

29032.7

0.26

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

233

1730

1.48

5.72

4.1

3.0

ng/l

6148.2

1175.6

7.17

206

1460

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

324

2569

1.42

5.57

4.6

3.4

ng/l

80.7

41.8

0.83

264

1709

(3023183) Ammonium ion [Moles/volume] in Plasma

174

2.30

5.40

5.7

3.4

umol/l

28.7

34.5

1.13

147

(3022621) pH of Urine by Test strip

397

1.86

5.40

6.1

2.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.77

5.38

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

124

812

1.62

5.37

4.1

2.9

umol/l

8.2

8.7

0.11

109

719

(3048689) Calprotectin [Mass/mass] in Stool

132

882

1.59

5.26

2.8

2.4

ug/g

117.6

124.7

0.13

113

717

(40768804) Tissue Pathology biopsy report

329

2636

1.40

5.25

2.3

2.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.69

5.22

1.3

2.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

729

6714

1.55

5.17

42.6

13.9

37.5

40.9

26.15

563

5111

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

140

2.41

5.12

1.5

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

281

1.98

5.08

2.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

5.31

5.05

6.4

7.9

—

(3026726) Creatinine [Moles/volume] in Specimen

10.09

5.03

6.1

1.9

umol/l

413.4

267.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

737

6820

1.55

4.94

7.2

4.2

mmol/l

6.0

0.47

712

6279

(3000570) Elastase.pancreatic [Mass/mass] in Stool

208

2.12

4.92

1.6

1.5

ug/g

273.4

285.1

0.15

122

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

179

1296

1.48

4.92

1.7

pmol/l

447.6

41795527.4

1.66

166

1103

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

3.53

4.91

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

170

2.23

4.81

2.2

1.7

e6/l

12498.2

13425.1

0.07

128

(3011985) Renin [Units/volume] in Plasma

2.79

4.81

1.4

1.3

mu/l

135.5

53.3

0.56

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.63

4.79

3.5

4.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

11.52

4.79

1.5

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

552

1.68

4.77

2.4

2.3

ug/l

3.9

8.7

4.17

504

(3004616) Nuclear Ab [Presence] in Serum

2.88

4.68

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

485

1.72

4.66

2.8

ng/l

506.7

165.4

2.70

433

(3025941) Bacteria identified in Stool by Culture

387

1.79

4.61

1.4

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

571

5068

1.37

4.59

4.9

3.2

u/l

56.4

50.3

0.89

548

4790

(3044007) Cell count panel - Peritoneal fluid

4.44

4.57

6.0

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

4.44

4.57

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

684

6270

1.44

4.46

4.8

4.2

mu/l

1.9

2.2

0.55

659

5764

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

172

2.14

4.28

1.5

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.91

4.26

1.2

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.91

4.26

1.2

2.4

—

(3042631) Mycobacterium sp identified in Specimen

2.60

4.24

2.6

2.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.45

4.20

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.70

4.18

1.1

1.3

nmol/l

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

202

2.03

4.13

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

202

2.03

4.13

1.3

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

204

1561

1.40

4.11

1.3

1.2

u/ml

3.7

1.2

0.72

435

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

2.67

4.09

1.4

pmol/l

348.8

351.9

0.01

(3024891) Influenza virus A+B Ag [Presence] in Specimen

203

2.02

4.08

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

205

2.00

3.98

1.3

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.85

3.97

1.2

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.85

3.97

1.2

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.85

3.97

1.2

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

248

1.90

3.96

1.2

1.3

miu/ml

123.0

215.3

—

120

(40768797) Stomach Pathology biopsy report

128

904

1.49

3.95

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

119

2.31

3.91

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

568

5103

1.33

3.81

3.9

3.6

pmol/l

14.6

14.7

0.32

538

4661

(40768806) Pleura Pathology biopsy report

2.76

3.77

1.2

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

12.07

3.76

1.2

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

224

1.92

3.75

1.4

1.2

titre

50.0

88.4

—

(21494755) Public health laboratory ask at order entry panel

891

0.58

3.74

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.04

3.70

5.9

1.9

e6/l

1664.0

2766.8

—

(3014051) Protein [Presence] in Urine by Test strip

129

2.21

3.67

6.4

1.8

—

(3023419) Bacteria identified in Sputum by Culture

2.45

3.66

1.9

2.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

2.45

3.66

1.0

—

(3004451) EKG impression Narrative

3.28

3.63

1.5

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

540

0.48

3.53

1.4

—

(3034426) Prothrombin time (PT)

3.88

3.53

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

6.20

3.50

1.3

2.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

230

0.30

3.49

1.1

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.37

3.48

1.2

2.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.37

3.48

1.2

2.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.37

3.48

1.2

2.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.37

3.48

1.2

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

116

824

1.47

3.48

1.6

1.7

—

(4306422)

119

2.22

3.47

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

799

0.58

3.45

1.5

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.47

3.34

1.2

2.3

—

(3011412) CD3 cells [#/volume] in Blood

2.57

3.31

1.4

2.1

e9/l

1.0

1.2

—

(3002256) Pathology report gross observation

118

850

1.45

3.30

1.4

1.2

—

(3045788) Cell count panel - Pleural fluid

2.81

3.26

1.3

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.05

3.26

3.3

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.60

3.20

1.3

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

2.89

3.20

1.3

2.2

12.0

15.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

262

1.76

3.09

2.3

2.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

196

1.87

3.06

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.26

3.06

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.26

3.06

1.5

1.4

—

(4062490)

2.53

3.05

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.53

3.05

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.04

3.05

1.1

2.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.87

3.02

1.1

—

(3013512) EKG study

233

1901

1.31

3.00

4.5

3.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2.26

2.98

4.0

2.9

nmol/l

0.8

0.9

0.62

(3004716) Salmonella sp identified in Stool by Organism specific culture

367

1.62

2.95

1.4

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.85

2.93

1.8

1.5

u/l

4.7

—

(3000494) Fungus identified in Specimen by Culture

117

863

1.41

2.89

1.8

1.5

—

(3007461) Platelets [#/volume] in Blood

827

8015

1.76

2.87

59.2

19.3

e9/l

244.0

247.2

0.77

819

7826

(3024263) Appearance of Synovial fluid

3.08

2.81

2.5

1.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.49

2.80

1.4

17.0

26.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

2.29

2.78

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

169

1331

1.34

2.78

1.6

1.5

—

(3026361) Erythrocytes [#/volume] in Blood

827

8022

1.74

2.76

59.1

19.3

e12/l

4.3

4.6

36.15

818

7818

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

2.88

2.76

1.8

2.2

ug/min

424.2

227.1

—

(3010813) Leukocytes [#/volume] in Blood

827

8024

1.73

2.73

59.2

19.4

e9/l

7.2

6.7

7.69

818

7816

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

357

3104

1.26

2.72

3.9

4.5

ug/l

2.0

2.3

0.74

336

2801

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

198

1.80

2.67

1.0

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

2.41

2.64

1.4

g/l

2.5

2.9

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

2.41

2.64

1.4

g/l

0.6

0.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

2.41

2.64

1.4

g/l

6.1

7.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

237

1.72

2.62

4.3

4.0

mmol/l

1.2

1.4

0.53

232

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

128

1.98

2.57

1.2

1.0

u/ml

3.2

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.38

2.57

4.3

3.5

—

(4024509)

2.75

2.55

4.4

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

7.18

2.55

1.0

—

(3044941) Cell count panel - Synovial fluid

108

2.06

2.53

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.41

2.47

1.5

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.48

2.46

1.2

1.1

—

(3022145) Colonoscopy Study observation

107

801

1.38

2.44

1.4

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.96

2.42

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.44

2.38

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.40

2.30

1.2

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

2.30

2.25

2.5

2.1

e6/l

780.6

771.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.07

2.23

1.4

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

5.58

2.21

1.0

4.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.35

2.18

1.1

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

2.04

2.17

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

2.04

2.17

1.3

1.5

—

(3022689) Creatine [Moles/volume] in Urine

4.31

2.15

2.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

2.02

2.12

1.3

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.02

2.12

1.4

1.5

—

(3028433) Virus identified in Specimen by Culture

3.22

2.10

1.3

1.5

—

(3019174) dRVVT (LA screen)

5.02

2.07

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.56

1.94

1.0

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.56

1.94

1.2

2.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.56

1.94

1.0

1.4

umol/24h

1.1

2.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

2.13

1.93

1.3

1.2

nmol/l

1.3

1.6

0.39

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.20

1.88

1.0

1.2

—

(3033799) Differential panel - Peritoneal fluid

3.20

1.88

2.3

2.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

245

1.58

1.87

2.1

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

142

1155

1.27

1.85

1.4

1.3

iu/ml

47.3

32.3

0.32

352

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.18

1.82

1.0

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

102

796

1.32

1.81

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.06

1.80

1.1

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.77

1.79

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.91

1.76

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

103

810

1.31

1.74

1.4

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.93

1.72

8.4

3.0

—

(3052592) Norovirus Ag [Presence] in Stool

3.86

1.71

1.6

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.81

1.65

1.4

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.51

1.60

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.35

1.52

1.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.35

1.52

5.0

8.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

1.52

0.0

2.9

—

53.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.17

1.51

1.8

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

773

1.29

1.51

17.7

6.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

132

1.68

1.47

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.05

1.44

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.91

1.39

1.4

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

142

1.64

1.39

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.21

1.37

1.1

—

(3000012) Reticulocyte production index

2.62

1.37

1.3

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

265

1.45

1.36

1.8

1.4

u/l

10.2

7.9

0.48

217

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.95

1.36

3.4

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

1.34

0.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.82

1.32

4.2

3.9

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.37

1.29

1.3

2.9

u/ml

1157.0

1471.9

—

(1761868) Lipid panel - Serum or Plasma

256

2847

0.86

1.29

3.8

2.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.79

1.28

1.4

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.79

1.28

1.2

4.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.79

1.28

1.4

1.1

—

(3017732) Neutrophils [#/volume] in Blood

468

1.33

1.27

3.1

2.8

e9/l

4.9

4.1

1.25

380

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.30

1.27

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

304

1.40

1.25

11.6

3.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

123

1.64

1.25

1.0

1.1

—

10.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.41

1.24

1.3

1.8

ug/l

88.3

56.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.41

1.24

1.5

2.2

—

(3017569) Oxygen content in Arterial blood

2.23

1.24

1.6

3.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.64

1.21

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.17

1.21

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

392

0.68

1.18

1.3

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

1.89

1.18

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

129

1095

1.21

1.18

1.4

1.3

u/ml

9.9

10.3

0.03

447

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.51

1.15

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.51

1.15

1.6

1.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.51

1.15

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

225

1.44

1.13

1.4

2.5

u/l

255.3

3060.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.34

1.12

1.1

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.01

1.12

7.3

3.4

—

(3005033) Fetal Nuchal fold Thickness US

147

0.54

1.04

1.8

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

148

0.54

1.04

1.8

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.28

1.03

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

151

0.53

1.03

1.8

1.5

—

(4094501)

197

1.44

1.01

1.0

1.1

—

(4034850)

214

1.42

1.01

13.4

10.1

—

(3006653) Thiamine [Moles/volume] in Blood

1.95

0.97

1.9

1.3

nmol/l

151.1

152.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

108

1.59

0.97

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

108

1.59

0.97

1.9

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.77

0.94

1.3

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.23

0.93

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.68

0.92

1.2

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.68

0.92

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.87

0.87

3.3

2.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

178

1.42

0.87

3.0

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.94

0.84

1.0

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.78

0.84

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.78

0.84

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

1.75

0.82

1.4

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

130

1.47

0.81

1.1

u/ml

7.8

2.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

233

1.34

0.80

1.6

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

114

1.50

0.80

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

1.82

0.79

4.0

2.2

—

(3011288) Drugs identified in Urine by Screen method

257

0.69

0.78

1.9

3.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

0.76

0.0

1.4

—

9.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1.61

0.75

4.1

2.4

mg/l

23.4

22.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.01

0.72

1.6

3.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.01

0.72

1.6

3.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

182

0.65

0.71

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

182

0.65

0.71

1.6

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

109

1.48

0.71

1.0

u/ml

0.5

2.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

837

1.17

0.70

6.1

4.3

31.0

31.2

0.12

586

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

181

0.66

0.70

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

181

0.66

0.70

1.6

1.4

—

(36660697) Celiac disease serology panel - Serum

530

1.20

0.69

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.86

0.68

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

393

1.23

0.68

3.4

3.5

pmol/l

3.9

4.6

4.13

350

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

362

0.77

0.68

1.0

—

(3028300) Cannabinoids [Presence] in Urine

373

0.77

0.67

1.6

2.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.63

0.67

2.3

3.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.79

0.66

1.8

1.3

—

(3027008) Opiates [Presence] in Urine

371

0.77

0.65

1.6

2.5

—

(40768441) Liver Pathology biopsy report

1.62

0.65

1.9

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

163

1.36

0.64

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

189

0.68

0.64

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.73

0.64

1.6

2.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.73

0.64

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

369

0.78

0.63

1.6

2.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.64

0.62

1.1

—

(4211845)

1.67

0.61

1.6

3.0

—

(3016879) Cocaine [Presence] in Urine

345

0.78

0.61

1.6

2.6

—

(3027944) Amphetamines [Presence] in Urine

367

0.78

0.61

1.6

2.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.48

0.61

1.3

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.57

0.60

1.8

2.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

122

1.40

0.60

1.2

1.1

g/l

1.5

0.00

108

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.57

0.58

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

141

1.36

0.56

2.1

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.46

0.56

1.9

1.5

g/l

0.9

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

205

0.73

0.54

1.3

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

116

1.39

0.54

1.0

u/ml

8.7

8.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

458

0.82

0.54

1.2

iu/ml

92.3

153.2

0.62

176

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

127

1.35

0.50

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

121

1.33

0.44

2.8

3.2

u/ml

46.4

36.4

0.07

114

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

162

0.74

0.42

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.57

0.42

1.8

2.4

—

(3023410) Appearance of Cerebral spinal fluid

1.43

0.42

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

103

1125

0.90

0.41

1.8

2.0

1.8

1.5

2.14

997

(21494434) Karyotype in Bone marrow

1.34

0.40

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

421

0.85

0.40

1.1

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.43

0.39

1.2

1.9

—

1021375.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.43

0.39

1.2

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.33

0.37

1.5

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.35

0.37

2.8

2.6

—

(40768793) Breast Pathology biopsy report

116

0.69

0.37

1.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

651

1.12

0.36

2.8

4.6

ug/l

19.0

28.6

0.21

538

(44813793)

1.40

0.35

1.3

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.34

0.34

1.2

—

(3008898) HLA-B27 [Presence]

303

1.16

0.33

1.1

—

(40768800) Prostate Pathology biopsy report

176

0.79

0.32

1.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

164

0.79

0.31

2.3

3.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

293

0.85

0.30

1.6

2.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

804

1.09

0.30

2.4

2.3

nmol/l

13.2

13.5

0.14

723

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

256

2461

1.06

0.30

3.4

3.9

28.7

21.1

7.76

119

1077

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

469

0.89

0.27

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.25

0.27

1.1

1.5

—

(40768795) Lymph node Pathology biopsy report

1.25

0.27

1.0

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

120

0.75

0.27

4.0

6.0

umol/l

325.2

366.3

—

107

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.28

0.26

1.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

114

1.23

0.25

2.1

1.7

—

(4198724)

1.32

0.23

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

125

1.20

0.22

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.21

0.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

2.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.21

0.0

1.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.9

—

76.9

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.16

0.21

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

83.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

166

0.84

0.20

8.1

4.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.20

0.0

1.1

—

0.4

—

(3005570) Glucose [Moles/volume] in Urine

1.21

0.18

1.1

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

371

0.91

0.17

1.5

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

882

0.95

0.16

1.7

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

193

0.88

0.16

1.8

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.78

0.15

1.2

1.0

mg/l

243.3

277.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

186

1807

1.04

0.15

2.5

2.8

ug/l

1.0

0.7

2.06

139

1117

(1002224) Polysomnography panel

371

1.08

0.15

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

1.14

0.15

1.8

1.3

—

(4146454)

1.13

0.15

3.4

2.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.09

0.14

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

103

1.17

0.13

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

304

0.92

0.13

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.17

0.13

1.4

1.5

—

(4010399)

474

1.06

0.11

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

311

0.93

0.10

2.0

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

961

0.96

0.10

1.8

2.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.04

0.09

1.4

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.07

0.08

1.3

1.7

—

(3025130) Human papilloma virus identified in Specimen

0.82

0.07

1.0

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

294

1.06

0.07

1.6

1.3

iu/l

20.5

22.0

0.11

243

(3000492) Spirometry study

771

1.03

0.06

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

152

0.99

0.00

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

182

0.99

0.00

1.5

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

151

0.99

0.00

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

155

0.97

0.00

1.3

1.2

e6/l

66.1

11.6

—

124

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

155

0.97

0.00

1.3

e6/l

743.6

808.9

—

128

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

5.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.01

0.00

1.3

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

198.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.90

0.00

1.1

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

39.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

6.8

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

9.7

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

6.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.0

4.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.0

4.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

140

1.00

0.00

1.4

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.97

0.00

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.96

0.00

1.1

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

10.9

—

(4281824)

0.94

0.00

1.8

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.93

0.00

3.5

2.8

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.0

4.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_IGA_NEPHROPATHY and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_IGA_NEPHROPATHY	2.567 [2.14, 3.08]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.191

During the follow-up period (1.1.1998 — 31.12.2019), 172 out of 1288 females with N14_IGA_NEPHROPATHY died.

Males

Parameter	HR [95% CI]	p-value
N14_IGA_NEPHROPATHY	2.249 [1.99, 2.54]	< 0.001
Birth year	0.985 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 541 out of 2443 males with N14_IGA_NEPHROPATHY died.

Mortality risk

Mortality risk for people of age

years, who have N14_IGA_NEPHROPATHY.

N-year risk	Females	Males
1	0.264%	0.378%
5	1.454%	2.341%
10	3.623%	6.074%
15	7.022%	11.139%
20	12.642%	18.605%

Relationships between endpoints

↥

Index endpoint: N14_IGA_NEPHROPATHY – IgA nephropathy (IgA glomerulonephritis)

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

IgA nephropathy (IgA glomerulonephritis)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints